Moderna

FDA probe rattles confidence in mRNA future Longevity Technology12:34mRNA FDA Pharma

Moderna stock slides as FDA moves to tighten vaccine guidelines Proactive Investors (US)12:46FDA Nasdaq Moderna Vaccine

Moderna 2026 Covid and Rsv growth not enough to boost stock, Jefferies says Proactive Investors (US)11:44Nasdaq Stock Markets Markets

Moderna must face northwestern patent suit over Covid vaccine Bloomberg Law15:17Covid Coronavirus Vaccine Moderna Vaccine

Market movers: Charbone Hydrogen, Moderna, Synopsys... Proactive Investors (US)14:48Nasdaq Moderna Vaccine Global Stock Markets

Moderna falls after FDA vows to impose new vaccine requirements Yahoo! US09:21FDA Moderna Vaccine

Moderna (MRNA) just reclaimed the 200-day moving average Zacks10:36

Moderna (MRNA) recently broke out above the 50-day moving average Zacks10:36

Moderna (MRNA) recently broke out above the 20-day moving average Zacks10:39

“The next 5-years will see mRNA science evolve beyond infectious disease” BioSpectrum Asia12:27mRNA Moderna Vaccine Biotechnology

Latest News

Yesterday

CHMP Backs EU Approval of MRNA's New COVID-19 Vaccine mNexspike Zacks10:57 16-Dec-25

In the last 7 days

Moderna Museet seeks Curator of International Contemporary Art ArtDaily21:10 14-Dec-25

Moderna (MRNA): Reassessing Valuation After Recent Share Price Rebound and Stabilizing Revenue Trends Simply Wall St19:31 13-Dec-25

PayPal, SoundHound, Moderna, Devon, Bristol-Myers: Trending by Analysts TipRanks04:07 13-Dec-25

FDA probe rattles confidence in mRNA future Longevity Technology12:34 12-Dec-25

Moderna 2026 Covid and RSV growth not enough to boost stock, Jefferies says Proactive Investors (US)11:44 12-Dec-25

Nanexa collaboration to enhance Moderna’s mRNA drug delivery European Pharmaceutical Review10:22 12-Dec-25

RFK Jr.’s Former Group Urges FDA to Revoke COVID Vax Licenses Medpage Today17:01 11-Dec-25

MRNA January 2026 Options Begin Trading Nasdaq12:52 11-Dec-25

Moderna signs deal worth up to $503m with Nanexa Pharmaceutical Technology11:57 11-Dec-25

An Olympic-sized effort: CIOs prep for AI disruption in 2026 InformationWeek07:04 11-Dec-25

In the last month

Moderna, Pfizer, and BioNTech stock briefly dips on FDA Covid vaccine probe Investing.com14:26 9-Dec-25

Moderna (MRNA) Just Reclaimed the 200-Day Moving Average Zacks10:36 8-Dec-25

Moderna (MRNA) Recently Broke Out Above the 50-Day Moving Average Zacks10:36 8-Dec-25

Moderna (MRNA) Recently Broke Out Above the 20-Day Moving Average Zacks10:39 4-Dec-25

Future of Business: Moderna’s Founder on Innovation That Breaks Through Harvard Business Review08:56 4-Dec-25

Eikon Therapeutics Announces the Election of David W. Meline to its Board of Directors Business Wire (Press Release)08:05 2-Dec-25

Is Moderna Stock Underperforming the Nasdaq? Barchart04:30 2-Dec-25

S&P 500 Gains and Losses Today: Moderna Plunges; Synopsys Surges on Nvidia Deal Yahoo! US18:01 1-Dec-25

Moderna stock falls after FDA vows to impose new vaccine requirements Boston Globe17:12 1-Dec-25

Market movers: Charbone Hydrogen, Moderna, Synopsys... Proactive Investors (US)14:48 1-Dec-25

Top Stock Movers Now: Coinbase, Robinhood, Moderna, Synopsys, and More Yahoo! US13:36 1-Dec-25

Moderna stock slides as FDA moves to tighten vaccine guidelines Proactive Investors (US)12:46 1-Dec-25

Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino Yahoo! US12:35 1-Dec-25

“The next 5-years will see mRNA science evolve beyond infectious disease” BioSpectrum Asia12:27 1-Dec-25

Moderna Falls as FDA Vows to Impose New Vaccine Requirements (1) Bloomberg Law11:01 1-Dec-25

Moderna Falls After FDA Vows to Impose New Vaccine Requirements Yahoo! US09:21 1-Dec-25

Moderna Must Face Northwestern Patent Suit Over Covid Vaccine Bloomberg Law15:17 28-Nov-25

Nov. 25 Business Watch: Flexsys readies safer tire additive; Moderna halts trials of 3 mRNA drugs Chemical & Engineering News15:48 25-Nov-25

Proskauer Advises Ares Management on $1.5 Billion Five-Year Credit Facility for Moderna Proskauer Rose LLP10:31 25-Nov-25

Moderna CTO details production strategy shift Bizjournals05:18 25-Nov-25

Moderna Secures $1.5 Billion Credit Facility TipRanks17:03 24-Nov-25

Moderna is the S&P 500's most shorted stock: Here's why Yahoo! UK & Ireland12:34 24-Nov-25

Stockholm's Market Art Fair celebrates its 20th birthday next spring ArtDaily18:54 23-Nov-25

Moderna is most shorted stock in S&P 500 as Americans skip immunizations Yahoo! US11:07 23-Nov-25

Walid Raad brings Museum of Mortal Guilt and three major projects to Ljubljana ArtDaily19:58 22-Nov-25

Five Things To Know From Moderna’s Analyst Day Scrip Pharma Intelligence17:12 21-Nov-25

First Week of MRNA July 2026 Options Trading Nasdaq11:19 21-Nov-25

Moderna takes out $1.5B loan, outlines commercial and R&D strategy in bid to break even by 2028 FiercePharma14:59 20-Nov-25

Moderna secures $1.5B lifeline as it looks to break even in 2028 BioPharma Dive12:01 20-Nov-25

Moderna gets breathing room with $1.5 billion loan from Ares Boston Globe10:18 20-Nov-25

Moderna to onshore drug product manufacturing to Massachusetts Pharmaceutical Technology08:58 20-Nov-25

Moderna Announces Pipeline Progress and Strategy Update TipRanks07:38 20-Nov-25

Moderna invests $140m to onshore drug product manufacturing and complete US end-to-end mRNA network Manufacturing Chemist07:27 20-Nov-25

Moderna takes $1.5 billion loan, expects 10% revenue growth next year Yahoo! US07:19 20-Nov-25

Moderna Stock (MRNA) Faces a Cash Crunch Test as Analyst Day Arrives TipRanks06:57 20-Nov-25

Moderna blueprints $140M plant in bid to bring end-to-end mRNA production to US FiercePharma15:36 19-Nov-25

Moderna strengthens US mRNA manufacturing capabilities with over $140m investment European Pharmaceutical Review11:58 19-Nov-25

Moderna plans to add manufacturing in Mass., create ‘hundreds’ of jobs Bizjournals10:01 19-Nov-25

Moderna to complete US mRNA manufacturing network with $140 million investment Yahoo! US08:54 19-Nov-25

The Strange Afterlife of Hilma af Klint, Painting’s Posthumous Star The New Yorker06:17 16-Nov-25

view more headlines

16 Dec 10:57

About our Moderna news

Latest news on Moderna, a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.